KP Tissue Inc. (TSX:KPT)

KP Tissue Statistics

Total Valuation

KP Tissue has a market cap or net worth of CAD 111.15 million.

Market Cap	111.15M
Enterprise Value	n/a

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	Mar 31, 2026

Share Statistics

KP Tissue has 10.02 million shares outstanding. The number of shares has increased by 0.27% in one year.

Current Share Class	10.02M
Shares Outstanding	10.02M
Shares Change (YoY)	+0.27%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.67%
Owned by Institutions (%)	1.01%
Float	9.96M

Valuation Ratios

The trailing PE ratio is 13.05 and the forward PE ratio is 14.55.

PE Ratio	13.05
Forward PE	14.55
PS Ratio	n/a
PB Ratio	1.59
P/TBV Ratio	1.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.00

Current Ratio	1.00
Quick Ratio	1.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 12.21%.

Return on Equity (ROE)	12.21%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.32%
Revenue Per Employee	n/a
Profits Per Employee	3,150
Employee Count	2,700
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.75% in the last 52 weeks. The beta is 0.38, so KP Tissue's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+38.75%
50-Day Moving Average	10.91
200-Day Moving Average	9.99
Relative Strength Index (RSI)	53.36
Average Volume (20 Days)	11,953

Short Selling Information

The latest short interest is 273,691, so 2.74% of the outstanding shares have been sold short.

Short Interest	273,691
Short Previous Month	279,887
Short % of Shares Out	2.74%
Short % of Float	2.75%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	8.50M
Net Income	8.50M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	0.85

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	69.80M
Book Value Per Share	6.97
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 6.49%.

Dividend Per Share	0.72
Dividend Yield	6.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	81.88%
Buyback Yield	-0.27%
Shareholder Yield	6.11%
Earnings Yield	7.65%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1